227 related articles for article (PubMed ID: 16827770)
21. [Antenatal anti-Rh(D) antigen prophylaxis].
Katsulov A;
Akush Ginekol (Sofiia); 2001; 40 Suppl 5():3-7. PubMed ID: 11785354
[No Abstract] [Full Text] [Related]
22. [Should the RhD prophylaxis be adjusted?].
Georgsen J; Sprogøe U
Ugeskr Laeger; 2004 Aug; 166(36):3072. PubMed ID: 15446237
[No Abstract] [Full Text] [Related]
23. Implementation of NICE recommendation for a policy of routine antenatal anti-D prophylaxis: a survey of UK maternity units.
Harkness M; Freer Y; Prescott RJ; Warner P
Transfus Med; 2008 Oct; 18(5):292-5. PubMed ID: 18937736
[TBL] [Abstract][Full Text] [Related]
24. RCM challenges new anti-D guidelines.
Pract Midwife; 1999 Nov; 2(10):7. PubMed ID: 12024565
[No Abstract] [Full Text] [Related]
25. Relevance of new recommendations on routine antenatal prevention of rhesus immunization: an appraisal based on a retrospective analysis of all cases observed in two French administrative areas of 3 million inhabitants.
Boulet S; Krause C; Tixier H; Bardou M; Sagot P
Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):65-70. PubMed ID: 19482403
[TBL] [Abstract][Full Text] [Related]
26. A review of maternal alloimmunisation to Rh D in Northern Ireland.
McCauley CJ; Morris K; Maguire K
Transfus Med; 2017 Apr; 27(2):132-135. PubMed ID: 28101958
[TBL] [Abstract][Full Text] [Related]
27. Study of compliance with a new, targeted antenatal D immunization prevention programme in Denmark.
Damkjaer MB; Perslev A; Clausen FB; Dziegiel MH; Jørgensen FS
Vox Sang; 2012 Aug; 103(2):145-9. PubMed ID: 22443522
[TBL] [Abstract][Full Text] [Related]
28. The scientific basis of antenatal prophylaxis.
Urbaniak SJ
Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():11-8. PubMed ID: 9863973
[TBL] [Abstract][Full Text] [Related]
29. An increased risk for non allo-immunization related intrauterine fetal death in RhD-negative patients.
Ben-David G; Sheiner E; Levy A; Erez O; Mazor M
J Matern Fetal Neonatal Med; 2008 Apr; 21(4):255-9. PubMed ID: 18330822
[TBL] [Abstract][Full Text] [Related]
30. Routine antenatal Rhesus D immunoglobulin prophylaxis: the results of a prospective 10 year study.
MacKenzie IZ; Bowell P; Gregory H; Pratt G; Guest C; Entwistle CC
Br J Obstet Gynaecol; 1999 May; 106(5):492-7. PubMed ID: 10430201
[TBL] [Abstract][Full Text] [Related]
31. [Rhesus prophylaxis--history and current status].
Behrens O; Lellé RJ
Zentralbl Gynakol; 1997; 119(5):204-10. PubMed ID: 9281253
[TBL] [Abstract][Full Text] [Related]
32. Time points and risk factors for RhD immunizations after the implementation of targeted routine antenatal anti-D prophylaxis: A retrospective nationwide cohort study.
Jernman R; Isaksson C; Haimila K; Kuosmanen M; Mäkikallio-Anttila K; Toivonen S; Ordén MR; Sulin K; Tihtonen K; Vääräsmäki M; Sainio S
Acta Obstet Gynecol Scand; 2021 Oct; 100(10):1868-1875. PubMed ID: 34157128
[TBL] [Abstract][Full Text] [Related]
33. [Immunohematological surveillance of the pregnant woman: new prevention policy].
Mannessier L
Transfus Clin Biol; 2009 May; 16(2):195-200. PubMed ID: 19419894
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of 250 μg anti-D IgG in the third trimester of pregnancy: an observational study.
Tiblad E; Wikman A; Rane A; Jansson Y; Westgren M
Acta Obstet Gynecol Scand; 2012 May; 91(5):587-92. PubMed ID: 22352370
[TBL] [Abstract][Full Text] [Related]
35. [Prophylactic anti-D for RhD- patient in France: an hasty recommendation?].
Benachi A; Nisand I
J Gynecol Obstet Biol Reprod (Paris); 2007 Oct; 36(6):523-5. PubMed ID: 17651919
[No Abstract] [Full Text] [Related]
36. RhD negative women. Are we ready to change practice?
Wray J
Pract Midwife; 2000 Oct; 3(9):26-8. PubMed ID: 12026547
[No Abstract] [Full Text] [Related]
37. Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis.
Koelewijn JM; de Haas M; Vrijkotte TG; van der Schoot CE; Bonsel GJ
BJOG; 2009 Sep; 116(10):1307-14. PubMed ID: 19538414
[TBL] [Abstract][Full Text] [Related]
38. Rhesus sensitisation.
Allan A
Mod Midwife; 1995 Nov; 5(11):24-6. PubMed ID: 7583418
[No Abstract] [Full Text] [Related]
39. Efficacy and long-term effects of antenatal prophylaxis with anti-D immunoglobulin.
Thornton JG
Obstet Gynecol Surv; 1991 Feb; 46(2):102. PubMed ID: 1900123
[No Abstract] [Full Text] [Related]
40. Anti-D in Rh(D)-negative pregnant women: are at-risk pregnancies and deliveries receiving appropriate prophylaxis?
Koby L; Grunbaum A; Benjamin A; Koby R; Abenhaim HA
J Obstet Gynaecol Can; 2012 May; 34(5):429-435. PubMed ID: 22555135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
